K2 Principal Fund, L.P. Ironwood Pharmaceuticals Inc Transaction History
K2 Principal Fund, L.P.
- $210 Million
- Q3 2024
A detailed history of K2 Principal Fund, L.P. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 25,000 shares of IRWD stock, worth $92,750. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$92,750% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IRWD
# of Institutions
235Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$84.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$81.8 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$60.8 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$43.5 Million0.13% of portfolio
-
State Street Corp Boston, MA9.92MShares$36.8 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $568M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...